Provention Bio, Inc. (PRVB) CEO Ashleigh Palmer on Q2 2020 Results – Earnings Call Transcript

Provention Bio, Inc. (NASDAQ:PRVB) Q2 2020 Earnings Conference Call August 6, 2020 8:00 AM ET
Company Participants
Andrew Drechsler – CFO
Ashleigh Palmer – Co-Founder, President, CEO & Director
Jason Hoitt – Chief Commercial Officer
Francisco Leon – Co-Founder & Chief Scientific Officer
Conference Call Participants
Thomas Smith – SVB Leerink
Gregory Renza – RBC Capital Markets
Alethia Young – Cantor Fitzgerald & Co.
Justin Kim – Oppenheimer
David Hoang – SMBC

Click here to view the original article.